Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 8, 2014, Pages 1211-1216

  Fraser, Callum G ^a   Rubeca, Tiziana ^b   Rapi, Stefano ^c   Chen, Li Sheng ^d   Chen, Hsiu Hsiu ^e  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Molecular and Nutritional Epidemiology Unit Cancer   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

colorectal cancer; cut off concentrations; faecal haemoglobin; faecal immunochemical test; reference values; screening

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; FECES LEVEL; FEMALE; GEOGRAPHY; HUMAN; IMMUNOTURBIDIMETRY; ITALY; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; TAIWAN; TURBIDIMETRY; UNITED KINGDOM; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FECES; MASS SCREENING; PROCEDURES; SEX DIFFERENCE;

AGE FACTORS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MASS SCREENING; SEX FACTORS;

EID: 84904012066     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0115     Document Type: Article

References (23)

1. Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, et al. Use of faecal markers in screening for colorectal neoplasia: a European Group on Tumor Markers (EGTM) position paper. Int J Cancer 2011;128:3-11.
2. Halloran SP, Launoy G, Zappa M. International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-faecal occult blood testing. Endoscopy 2012;44(Suppl 3):SE65-87.
3. Tao S, Seiler CM, Ronellenfitsch U, Brenner H. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer. Acta Oncol 2013;52:1667-75.
4. Fraser CG. A future for faecal haemoglobin measurements in the medical laboratory. Ann Clin Biochem 2012;49:518-26.
5. Fraser CG, Allison JE, Young GP, Halloran SP. Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening. Clin Gastroenterol Hepatol 2013;11:839-40.
6. Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver 2014;6:117-30.
7. Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, et al. Association of FOBT-Assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007;96:218-21.
8. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55.
9. Digby J, Fraser CG, Carey FA, McDonald PJ, Strachan JA, Diament RH, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol 2013;66:415-9.
10. Omata F, Shintani A, Isozaki M, Masuda K, Fujita Y, Fukui T. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol 2011;23:1036-41.
11. Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut 2014;63:466-71.
12. Chen L-S, Yen AM, Chiu SH, Liao C-S, Chen H-H. Baseline immunochemical faecal occult blood test (iFOBT) concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011;12:551-8.
13. Chen LS, Yen AM, Fraser CG, Chiu SY, Fann JC, Wang PE, et al. Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. Br Med J Open 2013;3:e003740.
14. McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med 2011;50:935-40.
15. Steele RJ, McDonald PJ, Digby J, Brownle L, Strachan JA, Libby G, et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United Eur Gastroenterol J 2013;1:198-205.
16. Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, et al. Taiwan Community-based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004;100:1734-43.
17. Rubeca T, Rapi S, Confortini M, Brogioni M, Grazzini G, Zappa M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers 2006;21:157-61.
18. Rubeca T, Peruzzi B, Confortini M, Rapi S. Overall evaluation of an immunological latex agglutination system for fecal occult blood testing in the colorectal cancer screening program of Florence. Int J Biol Markers 2012;27:e195-202.
19. Fraser CG, Allison JE, Halloran SP, Young GP; Expert Working Group on Fecal Immunochemical Tests for Hemoglobin, Colorectal Cancer Screening Committee, World Endoscopy Organization A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012;104:810-4.
20. Massat NJ, Moss SM, Halloran SP, Duffy SW. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences. J Med Screen 2013;20:125-48.
21. World Health Organization. International Agency for Research in Cancer. Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide 2012. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed 25 December, 2013.
22. Clinical Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory-Approved guideline, 3rd ed. Wayne, PA: CLSI, 2008.
23. WEO CRCSC Expert working Group "FIT for Screening". Available from: http://www.worldendo.org/weo-crcsc-expert-workinggroup-fit-for-screening. html. Accessed 25 December, 2013.